LXRX Historical PE Ratio image   This LXRX PE ratio history page last updated 8/4/2022
LXRX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/2/2022
2.60-0.16-0.64NA
Q1 2022
5/5/2022
1.85-0.16-0.64NA
Q4 2021
2/28/2022
2.07-0.17-0.68NA
Q3 2021
11/3/2021
5.77-0.16-0.64NA
Q2 2021
7/30/2021
3.54-0.13-0.52NA
Q1 2021
5/6/2021
4.46-0.15-0.60NA
Q4 2020
3/10/2021
7.30-0.04-0.16NA
Q3 2020
10/29/2020
1.16-0.43-1.72NA
Q2 2020
7/30/2020
2.00-0.65-2.60NA
Q1 2020
4/27/2020
2.30-0.63-2.52NA
Q4 2019
3/12/2020
1.93-0.48-1.92NA
Q3 2019
11/7/2019
3.88-0.10-0.40NA
Q2 2019
7/31/2019
1.35-0.22-0.88NA
Q1 2019
5/1/2019
5.97-0.21-0.84NA
Q4 2018
3/13/2019
7.86-0.16-0.64NA
Q3 2018
11/1/2018
8.32-0.26-1.04NA
Q2 2018
7/30/2018
11.43-0.33-1.32NA
Q1 2018
5/3/2018
8.30-0.40-1.60NA
Q4 2017
2/22/2018
8.85-0.23-0.92NA
Q3 2017
11/8/2017
8.77-0.29-1.16NA
Q2 2017
8/1/2017
16.00-0.33-1.32NA
Q1 2017
5/2/2017
15.69-0.33-1.32NA
Q4 2016
3/3/2017
16.09-0.31-1.24NA
Q3 2016
11/1/2016
15.21-0.35-1.40NA
Q2 2016
8/4/2016
16.51-0.37-1.48NA
Q1 2016
5/3/2016
13.02-0.34-1.36NA
Q4 2015
3/1/2016
10.850.763.043.6
Q3 2015
11/6/2015
13.04-0.34-1.36NA
Q2 2015
8/7/2015
11.38-0.27-1.08NA
Q1 2015
4/29/2015
7.56-0.28-1.12NA
Q4 2014
3/4/2015
7.350.000.00NA
Q3 2014
11/4/2014
10.08-0.56-2.24NA
Q2 2014
8/7/2014
11.13-0.35-1.40NA
Q1 2014
5/8/2014
9.45-0.42-1.68NA
Q4 2013
2/17/2014
NA-11.90-47.60NA
Q3 2013
11/6/2013
15.33-0.42-1.68NA
Q2 2013
7/30/2013
17.15-0.42-1.68NA
Q1 2013
5/10/2013
13.93-0.35-1.40NA
Q4 2012
2/21/2013
13.65-0.35-1.40NA
LXRX PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/2/2022
2.60-0.16-0.65NA
Q1 2022
5/5/2022
1.85-0.16-0.62NA
Q4 2021
2/28/2022
2.07-0.17-0.61NA
Q3 2021
11/3/2021
5.77-0.16-0.48NA
Q2 2021
7/30/2021
3.54-0.13-0.75NA
Q1 2021
5/6/2021
4.46-0.15-1.27NA
Q4 2020
3/10/2021
7.30-0.04-1.75NA
Q3 2020
10/29/2020
1.16-0.43-2.19NA
Q2 2020
7/30/2020
2.00-0.65-1.86NA
Q1 2020
4/27/2020
2.30-0.63-1.43NA
Q4 2019
3/12/2020
1.93-0.48-1.01NA
Q3 2019
11/7/2019
3.88-0.10-0.69NA
Q2 2019
7/31/2019
1.35-0.22-0.85NA
Q1 2019
5/1/2019
5.97-0.21-0.96NA
Q4 2018
3/13/2019
7.86-0.16-1.15NA
Q3 2018
11/1/2018
8.32-0.26-1.22NA
Q2 2018
7/30/2018
11.43-0.33-1.25NA
Q1 2018
5/3/2018
8.30-0.40-1.25NA
Q4 2017
2/22/2018
8.85-0.23-1.18NA
Q3 2017
11/8/2017
8.77-0.29-1.26NA
Q2 2017
8/1/2017
16.00-0.33-1.32NA
Q1 2017
5/2/2017
15.69-0.33-1.36NA
Q4 2016
3/3/2017
16.09-0.31-1.37NA
Q3 2016
11/1/2016
15.21-0.35-0.30NA
Q2 2016
8/4/2016
16.51-0.37-0.29NA
Q1 2016
5/3/2016
13.02-0.34-0.19NA
Q4 2015
3/1/2016
10.850.76-0.13NA
Q3 2015
11/6/2015
13.04-0.34-0.89NA
Q2 2015
8/7/2015
11.38-0.27-1.11NA
Q1 2015
4/29/2015
7.56-0.28-1.19NA
Q4 2014
3/4/2015
7.350.00-1.33NA
Q3 2014
11/4/2014
10.08-0.56-13.23NA
Q2 2014
8/7/2014
11.13-0.35-13.09NA
Q1 2014
5/8/2014
9.45-0.42-13.16NA
Q4 2013
2/17/2014
NA-11.90-13.09NA
Q3 2013
11/6/2013
15.33-0.42-1.54NA
Q2 2013
7/30/2013
17.15-0.42NANA
Q1 2013
5/10/2013
13.93-0.35NANA
Q4 2012
2/21/2013
13.65-0.35NANA
Quotes delayed 20 minutes

Email EnvelopeFree LXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Lexicon Pharmaceuticals (LXRX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LYEL PE Ratio History
LYRA PE Ratio History
MACK PE Ratio History
MASI PE Ratio History
MBIO PE Ratio History
MBOT PE Ratio History
MBRX PE Ratio History
MCK PE Ratio History
MCRB PE Ratio History
MD PE Ratio History
How should the LXRX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Lexicon Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LXRX Historical PE Ratio page.

What is the average historical PE for LXRX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LXRX historical PE ratio using the annualized quarterly earnings method works out to 3.6.

What is the average historical PE for LXRX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LXRX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the LXRX Historical PE Ratio information for Lexicon Pharmaceuticals' stock. The average LXRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 3.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LXRX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LXRX historical PE result, against the recent PE: when this page was posted on 8/3/2022, the most recent closing price for LXRX had been 2.69, and the most recent quarterly earnings result, annualized, was 3.04. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent LXRX PE on 8/3/2022 based on annualized quarterly EPS was 0.9. Based on LXRX's history, that recent PE is low relative to the historical average, with the recent PE 75.0% lower than the historical average PE across our data set for Lexicon Pharmaceuticals.

For self directed investors doing their due diligence on LXRX or any other given stock, valuation analysis for LXRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Lexicon Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LXRX. Thanks for visiting, and the next time you need to research LXRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding VCO, RUSS market cap history, BCEI market cap history.

 

LXRX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.